Early use of glycoprotein IIb/IIIa inhibitors in non–ST-elevation acute myocardial infarction
- 28 June 2003
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 42 (1), 45-53
- https://doi.org/10.1016/s0735-1097(03)00514-x
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Comparison of Early Invasive and Conservative Strategies in Patients with Unstable Coronary Syndromes Treated with the Glycoprotein IIb/IIIa Inhibitor TirofibanNew England Journal of Medicine, 2001
- Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trialThe Lancet, 2001
- Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the U.S. from 1990 through 1999Journal of the American College of Cardiology, 2000
- ACC/AHA guidelines for the management of patients with unstable angina and non–st-segment elevation myocardial infarctionJournal of the American College of Cardiology, 2000
- Differences between men and women in the management of unstable angina pectoris (the Guarantee Registry)The American Journal of Cardiology, 1999
- Inhibition of Platelet Glycoprotein IIb/IIIa with Eptifibatide in Patients with Acute Coronary SyndromesNew England Journal of Medicine, 1998
- A Comparison of Aspirin plus Tirofiban with Aspirin plus Heparin for Unstable AnginaNew England Journal of Medicine, 1998
- Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction.Circulation, 1994
- Aspirin, Heparin, or Both to Treat Acute Unstable AnginaNew England Journal of Medicine, 1988
- Reducing Bias in Observational Studies Using Subclassification on the Propensity ScoreJournal of the American Statistical Association, 1984